{
  "ticker": "PTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969334",
  "id": "02969334",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250715",
  "time": "0918",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06lt1lb0n266t7.pdf",
  "summary": "### **Material Information Summary (ASX Announcement Review)**  \n\n**Type:** *Share Purchase Plan (SPP) Extension*  \n- **Structure:** SPP (retail offering) at **$0.040/share** (16.7% discount to 15-day VWAP).  \n- **Capital Target:** Up to **$7 million**.  \n- **Revised Closing Date:** **22 July 2025** (extended from 15 July).  \n- **Use of Funds:** Advance **PTX-100 Phase 2 clinical trials** for regulatory approval.  \n- **Key Dates:**  \n  - **Record Date:** 30 June 2025.  \n  - **Results Announcement:** 28 July 2025.  \n  - **Shares Issued:** 30 July 2025.  \n\n**Omitted:** Routine operational updates, director names, legal disclaimers.  \n\n**Note:** No changes to SPP terms other than timeline extension.",
  "usage": {
    "prompt_tokens": 2648,
    "completion_tokens": 201,
    "total_tokens": 2849,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T23:51:13.415210"
}